Janssen Pharmaceuticals, a division of Johnson & Johnson, is set to begin Phase II trials of its Covid-19 vaccine in Spain on Monday, the programme’s lead investigator told The Guardian today.
190 people will be participating in the trials, which will take place in three hospitals and last until September 22.